RGEN
Repligen Corp
Price:  
124.38 
USD
Volume:  
757,638.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-105.1%
Upside

As of 2025-09-19, the Relative Valuation of Repligen Corp (RGEN) is (6.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 124.38 USD, the upside of Repligen Corp based on Relative Valuation is -105.1%.

The range of the Relative Valuation is (6.31) - (6.19) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 25.7x - 29.0x 27.1x
Forward P/E multiples 24.4x - 25.2x 24.6x
Fair Price (6.31) - (6.19) (6.36)
Upside -105.1% - -105.0% -105.1%
124.38 USD
Stock Price
(6.36) USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2025-09-18 -502.16
2025-09-17 -485.78
2025-09-16 -487.24
2025-09-15 -462.79
2025-09-12 -461.98
2025-09-11 -486.27
2025-09-10 -489.20
2025-09-09 -482.93
2025-09-08 -491.11
2025-09-05 -506.82
2025-09-04 -490.62
2025-09-03 -472.72
2025-09-02 -491.07
2025-08-29 -497.70
2025-08-28 -497.09
2025-08-27 -483.70
2025-08-26 -490.26
2025-08-25 -493.39
2025-08-22 -507.75
2025-08-21 -486.84
2025-08-20 -494.61
2025-08-19 -502.50
2025-08-18 -504.86
2025-08-15 -505.94
2025-08-14 -515.28
2025-08-13 -517.35
2025-08-12 -493.96
2025-08-11 -455.22
2025-08-08 -453.39
2025-08-07 -461.90
2025-08-06 -456.12
2025-08-05 -471.50
2025-08-04 -474.02
2025-08-01 -483.83
2025-07-31 -476.34
2025-07-30 -499.86
2025-07-29 -509.83
2025-07-28 -486.84
2025-07-25 -495.32
2025-07-24 -495.87
2025-07-23 -476.58
2025-07-22 -464.34
2025-07-21 -467.10
2025-07-18 -473.00
2025-07-17 -504.70
2025-07-16 -487.24
2025-07-15 -480.53
2025-07-14 -493.67
2025-07-11 -529.72
2025-07-10 -545.23